Chimeric antigen receptor T-cell therapy for solid tumors

by Kheng Newick, Edmund Moon, Steven M Albelda
Published 2016-01-01

Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.

by Kheng Newick, Brian Cunniff, Kelsey Preston, Paul Held, Jack Arbiser, Harvey Pass, Brooke Mossman, Arti Shukla, Nicholas Heintz
Published 2012-01-01

Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.

by Brian Cunniff, Kheng Newick, Kimberly J Nelson, Alexandra N Wozniak, Stacie Beuschel, Bruce Leavitt, Anant Bhave, Kelly Butnor, Andreas Koenig, Edward T Chouchani, Andrew M James, Alexina C Haynes, W Todd Lowther, Michael P Murphy, Arti Shukla, Nicholas H Heintz
Published 2015-01-01

Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity

by Liqing Wang, Suresh Kumar, Satinder Dahiya, Feng Wang, Jian Wu, Kheng Newick, Rongxiang Han, Arabinda Samanta, Ulf H. Beier, Tatiana Akimova, Tricia R. Bhatti, Benjamin Nicholson, Mathew P. Kodrasov, Saket Agarwal, David E. Sterner, Wei Gu, Joseph Weinstock, Tauseef R. Butt, Steven M. Albelda, Wayne W. Hancock
Published 2016-11-01